These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39058583)
1. Synthesis and characterization of nano-biopolymer carriers loaded with clove ( Ansari M; Ravan Avard E; Sharififar F; Mohamadi N J Biomater Sci Polym Ed; 2024 Oct; 35(15):2363-2379. PubMed ID: 39058583 [TBL] [Abstract][Full Text] [Related]
2. Chitosan-tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and antiulcerogenic activity. Servat-Medina L; González-Gómez A; Reyes-Ortega F; Sousa IM; Queiroz Nde C; Zago PM; Jorge MP; Monteiro KM; de Carvalho JE; San Román J; Foglio MA Int J Nanomedicine; 2015; 10():3897-909. PubMed ID: 26089666 [TBL] [Abstract][Full Text] [Related]
3. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer. Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294 [TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
5. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide. Kushwaha K; Dwivedi H Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624 [TBL] [Abstract][Full Text] [Related]
6. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R; Yallamalli IM; Yalavarthi PR Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [No Abstract] [Full Text] [Related]
8. Comparative anticancer potential of clove (Syzygium aromaticum)--an Indian spice--against cancer cell lines of various anatomical origin. Dwivedi V; Shrivastava R; Hussain S; Ganguly C; Bharadwaj M Asian Pac J Cancer Prev; 2011; 12(8):1989-93. PubMed ID: 22292639 [TBL] [Abstract][Full Text] [Related]
9. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications. Wang F; Yang S; Yuan J; Gao Q; Huang C J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731 [TBL] [Abstract][Full Text] [Related]
11. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method. Gupta M; Marwaha RK; Dureja H Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345 [TBL] [Abstract][Full Text] [Related]
12. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs. Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325 [TBL] [Abstract][Full Text] [Related]
13. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840 [TBL] [Abstract][Full Text] [Related]
14. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers. Raja MA; Katas H; Jing Wen T PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222 [TBL] [Abstract][Full Text] [Related]
15. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies. Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341 [TBL] [Abstract][Full Text] [Related]
16. Hybrid chitosan-lipid nanoparticles of green tea extract as natural anti-cellulite agent with superior Abosabaa SA; Arafa MG; ElMeshad AN Drug Deliv; 2021 Dec; 28(1):2160-2176. PubMed ID: 34623203 [TBL] [Abstract][Full Text] [Related]
17. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma. Lee SY; Koo JS; Yang M; Cho HJ J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352 [TBL] [Abstract][Full Text] [Related]
18. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: Aljaeid BM; El-Say KM; Hosny KM Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977 [No Abstract] [Full Text] [Related]